Infuse Open-Access Project A Model For The Future? Medtronic Thinks So
This article was originally published in The Gray Sheet
Executive Summary
Two independent analyses published last week on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis, both Medtronic and academic proponents say.
You may also be interested in...
TCT 2016: Researchers Argue For More Medtech Data Sharing
Device companies are not stepping up as much as they should be to make their raw trial data available for analysis by independent researchers, cardiologists said at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Journal Editors Press For More Disclosure Of Underlying Trial Data
The International Committee of Medical Journal Editors is collecting feedback on its plan to require clinical trial investigators to disclose patient-level data as a condition of publication.
Journal Editors Press For More Disclosure Of Underlying Trial Data
The International Committee of Medical Journal Editors is collecting feedback on its plan to require clinical trial investigators to disclose patient-level data as a condition of publication.